LPCN

Conviction 9HealthcareScan · Mon, Aug 10, 2026

LPCN$2.10-1.41%

ResistanceSupportVol 14

Vol MA14 48.26K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Lipocine Inc.PHARMACEUTICAL PREPARATIONSwww.lipocine.com ↗

Price2.10

Change-1.41%

Gap+3.29%

Rel volume1.22×

Avg volume41.38K

Avg $ vol89.02K

SMA 202.17

SMA 502.26

SMA 2004.56

Price vs 50-7.11%

Price vs 200-53.95%

MA stackbearish

50/200 cross—

Supertrendup · 2.02

RSI (14)40

MACD hist0.00

MACD crossbull · 2d

Stoch %K / %D29 / 38

ADX (14)14

+DI / −DI19 / 17

RSI divergence—

MACD divergenceBullish

ATR %+5.92%

ADR %5.02%

52w high11.26

52w low1.94

From 52w high-81.35%

Above 52w low+8.25%

New 52w highNo

SqueezeOn · 3d

Bollinger width14.15%

%B0.28

Donchian pos18.92%

Donchian high2.40

Donchian low2.03

AVWAP (52w high)3.48

vs AVWAP high-39.63%

AVWAP (52w low)2.14

vs AVWAP low-1.98%

OBV trendFlat

Chaikin MF (20)-0.40

Today vs 20d1.22×

Avg vol (14d)48.26K

Avg vol (20d)41.38K

Avg $ vol (20d)89.02K

Market cap17.31M

RS 3m (vs SPY)-16.58%

RS 6m (vs SPY)-86.52%

RS line new highNo

Trend template1/8

Technical rank7.0

1 week-0.47%

1 month-12.86%

3 months-11.39%

6 months-75.27%

1 year-29.53%

YTD-73.75%

P/E-1.80

P/B0.80

P/S34.63

P/FCF-1.76

EPS-1.69

Div yield—

ROE-44.23%

ROA-40.39%

Debt/Eq0.13

Current11.48

EV/EBITDA-1.48

Gross margin—

Net margin—

Rev growth-96.90%

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value15.26M

Revenue54.99K

Net income-2.62M

Gross profit—

Free cash flow-9.85M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees14

ListedTue, Jun 5, 2012

Free float5.19M

Float %93.4%

Short interest123.02K

Days to cover3.0d

Short volume7.2%

Squeeze score23 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction9 / 100

Pattern quality—

Tech rank7.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.64

Support2.06

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LPCN

All disclosures →

No recent disclosed trades by Congress in LPCN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LPCN · 5 buys

Insider	Side	Shares	Value	Traded	Filed
Grissinger Michael Director · Stock Option (Right to Buy) · 2026-08-03	Grant	2K	$4K	2026-08-03	2026-08-07
Patel Mahesh V. Chief Executive Officer · Stock Option (Right to Buy) · 2026-06-29	Grant	52.78K	$131K	2026-06-29	2026-06-30
Jene Jill M. Director · Stock Option (Right to Buy) · 2026-06-03	Grant	1.76K	$4K	2026-06-03	2026-06-04
Higuchi John W. Director · Common Stock (Right to Buy) · 2026-06-03	Grant	1.76K	$4K	2026-06-03	2026-06-04
Ono Richard Dana Director · Common Stock (Right to Buy) · 2026-06-03	Grant	1.76K	$4K	2026-06-03	2026-06-04

SEC filings

EDGAR filings in LPCN · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.